{
    "title": "More jobs under threat at AstraZeneca as firm hammers costs",
    "url": "https://www.dailymail.co.uk/money/article-1246869/More-jobs-threat-AstraZeneca-firm-hammers-costs.html",
    "date": "2010-01-28",
    "keywords": [
        "share",
        "cent",
        "company",
        "brennan",
        "year",
        "astrazeneca",
        "job",
        "loss",
        "price",
        "boss",
        "david",
        "plan",
        "dividend",
        "development",
        "industry",
        "companys",
        "exclusivity",
        "threat",
        "firm",
        "lyall",
        "mailonline",
        "gmt",
        "view",
        "round",
        "string",
        "yesterday",
        "value",
        "belowpar",
        "set",
        "backdrop",
        "overhaul",
        "business",
        "sop",
        "form",
        "buyback",
        "team",
        "shakeup",
        "giant",
        "workforce",
        "roster",
        "research",
        "group",
        "expertise",
        "failure",
        "market",
        "organisation",
        "order",
        "challenge",
        "government",
        "copycat",
        "competition",
        "selling",
        "school",
        "article",
        "pain",
        "pace",
        "breast",
        "cancer",
        "treatment",
        "arimidex",
        "medicine",
        "pulmicort",
        "panic",
        "heartburn",
        "pill",
        "nexium",
        "cholesterol",
        "buster",
        "crestor",
        "revenue",
        "base",
        "period",
        "product",
        "executive",
        "face",
        "rise",
        "performance",
        "part",
        "toprol",
        "blood",
        "pressure",
        "rush",
        "swine",
        "flu",
        "vaccine",
        "city",
        "az",
        "fall"
    ],
    "category": [
        "money"
    ]
}